Literature DB >> 17622717

Skeletal muscle morphology in patients with restless legs syndrome.

Britta Wåhlin Larsson1, Fawzi Kadi, Jan Ulfberg, Karin Piehl Aulin.   

Abstract

AIM: The aim of the study was to assess the cellular and structural properties of skeletal muscle in restless legs syndrome (RLS).
METHOD: Twenty patients and 16 controls were included. Aerobic performance was assessed using a submaximal test. On muscle biopsies taken from the tibialis anterior, fiber distribution and fiber area were analyzed together with parameters surveying the microvascularization, especially the tortuosity, which is expressed as a percent of muscle fiber perimeter in contact with the wall of the microvessel, length of capillary/perimeter of fiber (LC/PF) index.
RESULTS: The RLS group had significantly lower predicted maximal oxygen uptake (p = 0.01) and significantly higher LC/PF index (p = 0.01) compared to the controls.
CONCLUSION: The higher capillary tortuosity in RLS patients indicates the occurrence of significant remodeling in capillary geometry in RLS. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17622717     DOI: 10.1159/000104712

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  11 in total

1.  Periodic limb movements are associated with vasomotor symptoms.

Authors:  Jan Wesström; Jan Ulfberg; Inger Sundström-Poromaa; Eva Lindberg
Journal:  J Clin Sleep Med       Date:  2014-01-15       Impact factor: 4.062

2.  Decreased Symptoms without Augmented Skin Blood Flow in Subjects with RLS/WED after Vibration Treatment.

Authors:  Ulrike H Mitchell; Sterling C Hilton; Erik Hunsaker; Jan Ulfberg
Journal:  J Clin Sleep Med       Date:  2016-07-15       Impact factor: 4.062

3.  Iron and restless legs syndrome: treatment, genetics and pathophysiology.

Authors:  James R Connor; Stephanie M Patton; Konrad Oexle; Richard P Allen
Journal:  Sleep Med       Date:  2016-11-10       Impact factor: 3.492

4.  Pramipexole alters thermoregulation in restless legs syndrome.

Authors:  Aaro V Salminen; Ville Rimpilä; Olli Polo
Journal:  J Clin Sleep Med       Date:  2014-12-15       Impact factor: 4.062

Review 5.  Restless Leg Syndrome/Willis-Ekbom Disease Pathophysiology.

Authors:  Richard P Allen
Journal:  Sleep Med Clin       Date:  2015-07-15

6.  Restless legs syndrome status as a predictor for lower physical function.

Authors:  Chunbai Zhang; Yanping Li; Atul Malhotra; Yi Ning; Xiang Gao
Journal:  Neurology       Date:  2014-03-05       Impact factor: 9.910

Review 7.  Medical devices for restless legs syndrome - clinical utility of the Relaxis pad.

Authors:  Ulrike H Mitchell
Journal:  Ther Clin Risk Manag       Date:  2015-12-03       Impact factor: 2.423

8.  Evidence of increased muscle atrophy and impaired quality of life parameters in patients with uremic restless legs syndrome.

Authors:  Christoforos D Giannaki; Giorgos K Sakkas; Christina Karatzaferi; Georgios M Hadjigeorgiou; Eleftherios Lavdas; Vassilios Liakopoulos; Nikolaos Tsianas; Georgios N Koukoulis; Yiannis Koutedakis; Ioannis Stefanidis
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

9.  Peripheral Dopamine in Restless Legs Syndrome.

Authors:  Ulrike H Mitchell; J Daniel Obray; Erik Hunsaker; Brandon T Garcia; Travis J Clarke; Sandra Hope; Scott C Steffensen
Journal:  Front Neurol       Date:  2018-03-15       Impact factor: 4.003

10.  Serum endocan levels in women with restless legs syndrome.

Authors:  Kenan Celik; Mehmet A Cikrikcioglu; Gulistan Halac; Elif Kilic; Siddika Ayhan; Nihal Ozaras; Kemal Yildiz; Rabia S Yildiz; Mehmet Zorlu; Cumali Karatoprak; Mustafa Cakirca; Muharrem Kiskac
Journal:  Neuropsychiatr Dis Treat       Date:  2015-11-19       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.